Safety Thumbs Up For Zynteglo Prompts Bluebird To Lift Marketing Suspension
US Filing For The β-Thalassemia Gene Therapy Is On Track
No evidence has been found linking the viral vector in bluebird’s gene therapy for β-thalassemia to blood cancer, the European Medicines Agency says.
